tech2people

What tech2people does

tech2people GmbH operates a single-location outpatient neurorehabilitation therapy center in Vienna's Seestadt district (22nd district, 700m² facility inside the HoHo Next timber-hybrid building), opened in Fall 2023 after years of hospital-based treatments. The company combines conventional physiotherapy and occupational therapy with a multi-vendor robotic and sensor-based device portfolio that is unusual for an outpatient clinic in Austria: the EksoNR bionic exoskeleton, Lokomat Pro gait trainer with FreeD module, Pablo and Tymo sensor-based therapy systems, the C-Mill VR-enabled treadmill, and the Rysen ceiling-mounted bodyweight-support system. The center serves patients recovering from neurological conditions (stroke, multiple sclerosis, paraplegia/spinal cord injury, traumatic brain injury, Parkinson's disease, and infantile cerebral palsy), and packages these modalities into programs including intensive "Neuro Intensiv Wochen" (3-6 sessions/day over 2+ weeks) plus adjacent services such as medical training therapy, pediatric therapy, speech therapy, psychosocial and grief counseling, and case management.

Revenue is generated fee-for-service through outpatient therapy sessions billed to patients directly or reimbursed via Austrian public health insurance, with each patient requiring a valid medical prescription. Distribution is direct-to-consumer via online appointment booking, phone-based front office, and referral partnerships with organizations including Neurotherapists Austria, Abilitate, MyAbility, and Wiedergehen. The company is privately held by three co-founders (Gregor Demblin, Michael Seitlinger, Dennis Veit) with backing from Austrian Lotteries, Raiffeisen-Holding, UNIQA Foundation, EY Austria and Vienna Estate, and employs ~15 staff including therapists, operations, and clinical leadership.

The technology underpinnings are largely procured rather than proprietary: the core differentiation rests on integrating six leading robotic/sensor platforms under one outpatient roof, supported by in-house software for measuring therapy progress, a multilingual therapist team (8+ languages), and an advisory network anchored by the Chief Medical Advisor (head of neurology at Klinik Floridsdorf and chairman of the ÖGNR scientific advisory board) plus external spinal-cord neurophysiology experts delivered through Beyond Motor Limits. The company has no disclosed AI/ML products, no patents or trademarks on record, no institutional venture funding, and operates exclusively within Austria.

Name

tech2people

Legal name

tech2people GmbH

Website

https://tech2people.at

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

tech2people GmbH operates a single Vienna outpatient neurorehabilitation center combining conventional physiotherapy and occupational therapy with six robotic and sensor-based devices (EksoNR, Lokomat Pro, Pablo, Tymo, C-Mill, Rysen) to treat stroke, multiple sclerosis, spinal cord injury, Parkinson's, traumatic brain injury, and cerebral palsy patients on a fee-for-service basis reimbursed via Austrian public health insurance.

Ownership category

akta.pro rank

Product category

Outpatient Neurorehabilitation Services

NAICS

Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Neurorehabilitation Centers (HLAFAFAH)

akta.pro secondary industries

Neurologic Rehabilitation Centers (Stroke/TBI/SCI/MS/Parkinson’s) (HLADAJAH), Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)

Keywords

• Robotic neurorehabilitation
• Outpatient therapy services
• Exoskeleton gait training
• Physiotherapy services
• Occupational therapy

Headquarters

HQ city

Vienna

HQ country

Austria

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Outpatient Therapy Services: Fee-for-service outpatient neurorehabilitation including device-assisted robotic therapy, physiotherapy, occupational therapy, and related services. Billed to patients directly or reimbursed through Austrian public health insurance (requires valid medical prescription).

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

tech2people operates an outpatient neurorehabilitation therapy center in Vienna's Seestadt district, combining advanced robotic-assisted devices (EksoNR bionic exoskeleton, Lokomat Pro with FreeD module, Pablo and Tymo sensor systems, C-Mill VR-enabled treadmill, and Rysen bodyweight support system) with conventional physiotherapy and occupational therapy. The center treats patients with neurological conditions including stroke, multiple sclerosis, paraplegia, Parkinson's disease, traumatic brain injury, and infantile cerebral palsy. Services require a valid medical prescription and are reimbursed through Austrian public health insurance or self-pay.

Product overview

tech2people operates as an outpatient neuro-rehabilitation therapy center offering a unified treatment platform combining robotic-assisted therapy devices with conventional physiotherapy and occupational therapy. The core product portfolio includes the EksoNR exoskeleton, Lokomat Pro gait training system, Pablo and Tymo sensor-based therapy systems, Rysen ceiling-mounted gait trainer, and C-Mill VR-equipped treadmill. These devices are supported by the Neuro Intensive Weeks program, an intensive modular therapy regimen delivering 3-6 sessions daily over two or more weeks. The center treats neurological conditions including stroke, multiple sclerosis, paraplegia, Parkinson's disease, traumatic brain injury, and infantile cerebral palsy across a 700m² facility in Vienna's HoHo building.

Differentiator

Problem solved

Functional benefit

Products and services

• Neuro Intensive Weeks Program Intensive modular therapy program lasting two weeks or more with three to six therapy sessions per day for maximum rehabilitation progress. Designed for patients with neurological conditions seeking accelerated recovery outcomes.
• Robotic-Assisted Therapy (Gerätegestützte Therapie) Therapy with modern robotic systems to repeatedly and precisely train movements, especially for gait and arm functions when conventional methods are insufficient. Includes exoskeleton, robotic gait, sensor-based, and VR-enabled training modalities.
• Physiotherapy Individual physiotherapy sessions aimed at improving mobility, strength, and quality of life through targeted, safe, and sustainable treatment.
• Occupational Therapy (Ergotherapie) Therapy that strengthens everyday functional abilities, promotes independence, and improves quality of life for patients with neurological conditions.
• Medical Training Therapy (MTT) Targeted training for strength, endurance, and mobility, therapeutically supervised and individually tailored as a supplement to physiotherapy and occupational therapy.
• Pediatric Therapy (Pädiatrische Therapie) Individual support for movement, development, and independence in children with neurological conditions such as infantile cerebral palsy.
• Speech Therapy (Logopädie) Speech and language therapy supporting communication and swallowing functions, integrated into the neurorehabilitation therapy portfolio.
• Case Management Case management and psychosocial counseling helping patients navigate complex healthcare processes after life-changing diagnoses, provided by Dr. Bärbel Klepp through external practice care-for-you.at.
• Psychosocial Counseling Psychosocial counseling supporting patients in change processes, focusing on participation, self-efficacy, independence, and sustainable quality of life improvement.
• Grief Counseling (Trauerbegleitung) Grief counseling at health loss with university education in Psychological Crisis Management, accompanying people after life-changing diagnoses.
• Scientific Consulting Scientific consultations in neurophysiology and neuromodulation provided by Karen Minassian and Ursula Hofstötter through external company Beyond Motor Limits GesbR, including transcutaneous spinal cord stimulation advisory.

Quantifiable outcome

• Patients who received robot-assisted gait therapy (RAGT) after stroke had significantly higher chance of regaining independent walking ability compared to conventional physiotherapy (Cochrane Review evidence)
• +3 more outcomes

Named customers4 records

Segments6 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Vienna EstatecoreStrategic or Co-development PartnerVienna Estate is the owner of HoHo Vienna and the adjacent HoHo Next building where tech2people's therapy center is located. This partnership provides tech2people with its first-class, sustainable treatment environment in Vienna's Seestadt innovation district.
• Neurotherapists Austria (Neurotherapeutinnen)minorGTM or Marketing PartnerListed as a cooperation partner in the tech2people network. Neurotherapists Austria represents a network of neurological therapy professionals who may refer patients or collaborate on treatment approaches.
• AbilitateminorGTM or Marketing PartnerAbilitate is listed among tech2people's network partners, suggesting referral or collaborative relationships in the neurorehabilitation ecosystem.
• MyAbilityminorGTM or Marketing PartnerMyAbility is a network partner listed on the tech2people website. The company was founded by tech2people co-founder Gregor Demblin and focuses on accessibility and inclusion.
• WiedergehenminorGTM or Marketing PartnerWiedergehen is listed among tech2people's network partners, representing another player in the Austrian neurorehabilitation or disability services ecosystem.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• MEDIAN Kliniken: One of Germany's largest private operators of rehabilitation and acute-care hospitals, with extensive neurological rehab capacity across inpatient and outpatient settings. Represents the scaled incumbent model tech2people's evidence-based robotic approach must compete against for patient referrals and payer contracts.
• Asklepios Kliniken: Major German private hospital group with broad neurology and rehabilitation service lines. Relevant as a system-level incumbent with payer leverage and capital scale that could absorb robotic modalities across a much larger footprint if it elects to invest in the same device stack as tech2people.
• Helios Hospital Group: Large European hospital operator (Fresenius subsidiary) running inpatient and outpatient neurological rehab across Germany and Spain. Comparable on the broad clinical and operational stack but competes at very different scale and payer mix; useful benchmark for national-scale rehab operations.

Others

• Tyromotion: Austrian/European manufacturer of Pablo and Tymo sensor-based therapy systems deployed at tech2people. Domestic geographic peer and supplier; relevant because Tyromotion's product roadmap and clinical-evidence generation directly affect tech2people's therapy offering.
• Hocoma (DIH Medical): Swiss manufacturer of the Lokomat gait robot and part of DIH Medical. Direct device supplier to tech2people and shaper of the robotic neurorehab category; comparable as a strategic ecosystem peer whose commercial priorities influence tech2people's clinical differentiation.

Emerging players

• Ekso Bionics: US-listed manufacturer of the EksoNR exoskeleton used at tech2people. Strategic device partner and category creator; relevant as a peer because Ekso's own clinical-network strategy overlaps with tech2people's positioning as an outpatient flagship for the technology.
• ReWalk Robotics: Israeli/US exoskeleton manufacturer whose devices tech2people's CCO used to work on and whose EksoNR tech is deployed in the Vienna center. Strategic supply-side peer — overlapping technology category (wearable robotic gait) and increasingly competing at the patient/end-user level rather than purely as a device vendor.

Direct peers

• RehaNova Köln: Specialized outpatient neurological rehabilitation center in Cologne offering intensive therapy for stroke, MS, and Parkinson's patients. Comparable in being a dedicated neuro-only outpatient clinic rather than a general hospital — relevant benchmark for tech2people's site economics and patient throughput.
• P.A.N. Zentrum für Post-Akute Neurorehabilitation: Berlin-based outpatient center specializing in post-acute neurological rehabilitation with intensive, high-repetition therapy programs. Closest direct competitor to tech2people in operating model (outpatient neuro center, premium private/insurance-paid service, German-speaking market) and condition focus (stroke, TBI, MS, Parkinson's).
• Zentrum für ambulante Neurorehabilitation (ZAN) München: Outpatient neurorehabilitation center in Munich providing intensive neurological therapy programs with modern equipment. Direct competitor in the DACH outpatient neuro segment with similar focus on neurological conditions and intensive therapy packages.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat3 records

Key risks2 records

Key highlights2 records

Customer concentration

• YouTubeyoutube.com/@tech2people328
• LinkedInlinkedin.com/company/tech2people-at

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about tech2people